Naphthaquinone anti-psoriatic agents
US4229478A · kind A · utility
9Cited by
1References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 5, 1978 |
| Grant date | Oct 21, 1980 |
| Priority date | — |
| Expiry date | Jun 5, 1998 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C46/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Psoriasis in mammals is relieved by topically administering substituted naphthaquinones of the formula: ##STR1## where R.sup.1 and R.sup.2 are the same or different and are hydrogen, hydroxy, alkoxy or acylamino and R.sup.3 is hydrogen, halo, cyano or alkoxy with the proviso that R.sup.1 and R.sup.2 are not both hydrogen.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.